Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31532463.
- Also identified by DOI 10.1001/jamapsychiatry.2019.2563 and PMC identifier 6751777.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case series study provides a national estimate of opioid and benzodiazepine coprescribing before and after the US Food and Drug Administration (FDA) boxed warning.
Medical subject headings
- Analgesics, Opioid
- Benzodiazepines
- Drug Labeling
- Drug Prescriptions
- Practice Patterns, Physicians'
- United States Food and Drug Administration